Last year left us with this piece of bombshell news: He Jiankui, the mastermind behind the CRISPR babies scandal, has been sentenced to three years in prison for violating Chinese laws on scientific research and medical management. Two of his colleagues also face prison for genetically engineering human embryos that eventually became the worlds first CRISPRd babies.
The story isnt over: at least one other scientist is eagerly following Hes footsteps in creating gene-edited humans, although he stresses that he wont implant any engineered embryos until receiving regulatory approval.
Biotech stories are rarely this dramatic. But as gene editing tools and assisted reproductive technologies increase in safety and precision, were bound to see ever more mind-bending headlines. Add in a dose of deep learning for drug discovery and synthetic biology, and its fair to say were getting closer to reshaping biology from the ground upboth ourselves and other living creatures around us.
Here are two stories in biotech were keeping our eyes on. Although successes likely wont come to fruition this year (sorry), these futuristic projects may be closer to reality than you think.
The idea of human-animal chimeras immediately triggers ethical aversion, but the dream of engineering replacement human organs in other animals is gaining momentum.
There are two main ways to do this. The slightly less ethically-fraught idea is to grow a fleet of pigs with heavily CRISPRd organs to make them more human-like. It sounds crazy, but scientists have already successfully transplanted pig hearts into baboonsa stand-in for people with heart failurewith some recipients living up to 180 days before they were euthanized. Despite having foreign hearts, the baboons were healthy and acted like their normal buoyant selves post-op.
But for cross-species transplantation, or xenotransplants to work in humans, we need to deal with PERVsa group of nasty pig genes scattered across the porcine genome, remnants of ancient viral infections that can tag along and potentially infect unsuspecting human recipients.
Theres plenty of progress here too: back in 2017 scientists at eGenesis, a startup spun off from Dr. George Churchs lab, used CRISPR to make PERV-free pig cells that eventually became PERV-free piglets after cloning. Then last month, eGenesis reported the birth of Pig3.0, the worlds most CRISPRd animal to further increase organ compatibility. These PERV-free genetic wonders had three pig genes that stimulate immunorejection removed, and nine brand new human genes to make themin theorymore compatible with human physiology. When raised to adulthood, pig3.0 could reproduce and pass on their genetic edits.
Although only a first clinical propotype that needs further validation and refinement, eGenesis is hopeful. According to one (perhaps overzealous) estimate, the first pig-to-human xenotranplant clinical trial could come in just two years.
The more ethically-challenged idea is to grow human organs directly inside other animalsin other words, engineer human-animal hybrid embryos and bring them to term. This approach marries two ethically uncomfortable technologies, germline editing and hybrids, into one solution that has many wondering if these engineered animals may somehow receive a dose of humanness by accident during development. What if, for example, human donor cells end up migrating to the hybrid animals brain?
Nevertheless, this year scientists at the University of Tokyo are planning to grow human tissue in rodent and pig embryos and transplant those hybrids into surrogates for further development. For now, bringing the embryos to term is completely out of the question. But the line between humans and other animals will only be further blurred in 2020, and scientists have begun debating a new label, substantially human, for living organisms that are mainly human in characteristicsbut not completely so.
With over 800 gene therapy trials in the running and several in mature stages, well likely see a leap in new gene medicine approvals and growth in CAR-T spheres. For now, although transformative, the three approved gene therapies have had lackluster market results, spurring some to ponder whether companies may cut down on investment.
The research community, however, is going strong, with a curious bifurcating trend emerging. Let me explain.
Genetic medicine, a grab-bag term for treatments that directly change genes or their expression, is usually an off-the-shelf solution. Cell therapies, such as the blood cancer breakthrough CAR-T, are extremely personalized in that a patients own immune cells are genetically enhanced. But the true power of genetic medicine lies in its potential for hyper-personalization, especially when it comes to rare genetic disorders. In contrast, CAR-Ts broader success may eventually rely on its ability to become one-size-fits-all.
One example of hyper-tailored gene medicine success is the harrowing story of Mila, a six-year-old with Batten disease, a neurodegenerative genetic disorder that is always fatal and was previously untreatable. Thanks to remarkable efforts from multiple teams, however, in just over a year scientists developed a new experimental therapy tailored to her unique genetic mutation. Since receiving the drug, Milas condition improved significantly.
Milas case is a proof-of-concept of the power of N=1 genetic medicine. Its unclear whether other children also carry her particular mutationBatten has more than a dozen different variants, each stemming from different genetic miscodingor if anyone else would ever benefit from the treatment.
For now, monumental costs and other necessary resources make it impossible to pull off similar feats for a broader population. This is a shame, because inherited diseases rarely have a single genetic cause. But costs for genome mapping and DNA synthesis are rapidly declining. Were starting to better understand how mutations lead to varied disorders. And with multiple gene medicines, such as antisense oligonucleotides (ASOs) finally making a comeback after 40 years, its not hard to envision a new era of hyper-personalized genetic treatments, especially for rare diseases.
In contrast, the path forward for CAR-T is to strip its personalization. Both FDA-approved CAR-T therapies require doctors to collect a patients own immune T cells, preserved and shipped to a manufacturer, genetically engineered to boost their cancer-hunting abilities, and infused back into patients. Each cycle is a race against the cancer clock, requiring about three to four weeks to manufacture. Shipping and labor costs further drive up the treatments price tag to hundreds of thousands of dollars per treatment.
These considerable problems have pushed scientists to actively research off-the-shelf CAR-T therapies, which can be made from healthy donor cells in giant batches and cryopreserved. The main stumbling block is immunorejection: engineered cells from donors can cause life-threatening immune problems, or be completely eliminated by the cancer patients immune system and lose efficacy.
The good news? Promising results are coming soon. One idea is to use T cells from umbilical cord blood, which are less likely to generate an immune response. Another is to engineer T cells from induced pluripotent stem cells (iPSC)mature cells returned back to a young, stem-like state. A patients skin cells, for example, could be made into iPSCs that constantly renew themselves, and only pushed to develop into cancer-fighting T cells when needed.
Yet another idea is to use gene editing to delete proteins on T cells that can trigger an immune responsethe first clinical trials with this approach are already underway. With at least nine different off-the-shelf CAR-T in early human trials, well likely see movement in industrialized CAR-T this year.
Theres lots of other stories in biotech we here at Singularity Hub are watching. For example, the use of AI in drug discovery, after years of hype, may finally meet its reckoning. That is, can the technology actually speed up the arduous process of finding new drug targets or the design of new drugs?
Another potentially game-changing story is that of Biogens Alzheimers drug candidate, which reported contradicting results last year but was still submitted to the FDA. If approved, itll be the first drug to slow cognitive decline in a decade. And of course, theres always the potential for another mind-breaking technological leap (or stumble?) thats hard to predict.
In other words: we cant wait to bring you new stories from biotechs cutting edge in 2020.
Image Credit: Image by Konstantin Kolosov from Pixabay
More here:
The Top Biotech Trends We'll Be Watching in 2020 - Singularity Hub
- Singularity Future Technology Ltd (SGLY) is up 43.55% Tuesday In Premarket Trading - InvestorsObserver - March 18th, 2024 [March 18th, 2024]
- This Week's Awesome Tech Stories From Around the Web (Through March 16) - Singularity Hub - March 18th, 2024 [March 18th, 2024]
- Palia reaches over 3m players in six months thanks to "invaluable" Switch partnership - GamesIndustry.biz - March 18th, 2024 [March 18th, 2024]
- Beyond the Singularity: Exploring the Fusion of AI and Art - Hong Kong Standard - March 18th, 2024 [March 18th, 2024]
- Your Comprehensive Guide to Telos Staking Success | by Pizza Singularity Sapphire | Feb, 2024 - Medium - February 20th, 2024 [February 20th, 2024]
- BTS' Kim Taehyung's 'Singularity' Performance Featured in Harvard Professor's Book - BNN Breaking - February 20th, 2024 [February 20th, 2024]
- Title: Understanding the Singularity: Unveiling the Future of Humanity - Medium - December 12th, 2023 [December 12th, 2023]
- What happens at the center of a black hole? - Astronomy Magazine - December 12th, 2023 [December 12th, 2023]
- IBM Is Planning to Build Its First Fault-Tolerant Quantum Computer by 2029 - Singularity Hub - December 12th, 2023 [December 12th, 2023]
- 22 Laws of Singularity And How You Can Apply Them To Live A Better Life - Medium - December 12th, 2023 [December 12th, 2023]
- Singularity: Here's When Humanity Will Reach It, New Data Shows - March 31st, 2023 [March 31st, 2023]
- sentinelOne expands singularity marketplace with new SOAR, insider threat, training, and prioritization integrations - ZAWYA - March 31st, 2023 [March 31st, 2023]
- Reaching the Singularity May be Humanitys Greatest and Last ... - March 4th, 2023 [March 4th, 2023]
- Singularity: Explain It to Me Like I'm 5-Years-Old - Futurism - March 4th, 2023 [March 4th, 2023]
- SINGULARITY FUTURE TECHNOLOGY LTD. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in... - March 4th, 2023 [March 4th, 2023]
- Apple co-founder Steve Wozniak on Artificial Intelligence: Not worried about The Singularity, well still be in control - MacDailyNews - February 12th, 2023 [February 12th, 2023]
- Cauchy principal value - Wikipedia - January 4th, 2023 [January 4th, 2023]
- Singularity Future Technology Ltd. (SGLY) Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Against Singularity Future Technology... - December 14th, 2022 [December 14th, 2022]
- ROSEN, A LEADING LAW FIRM, Encourages Singularity Future Technology Ltd. f/k/a Sino-Global Shipping America Ltd. Investors to Secure Counsel Before... - December 12th, 2022 [December 12th, 2022]
- Singularity (mathematics) - Wikipedia - November 23rd, 2022 [November 23rd, 2022]
- GitHub: Where the world builds software GitHub - November 21st, 2022 [November 21st, 2022]
- Review: The Singularities, by John Banville - The New York Times - October 25th, 2022 [October 25th, 2022]
- We need to manage AI better as we are approaching the Creative Singularity - RedShark News - October 15th, 2022 [October 15th, 2022]
- This Week's Awesome Tech Stories From Around the Web (Through October 15) - Singularity Hub - October 15th, 2022 [October 15th, 2022]
- Ferguson: A second helping of QB play from Thanksgiving weekend - CFL.ca - October 15th, 2022 [October 15th, 2022]
- Kanimozhi slams Union govt over conducting CGL exams in only Hindi and English - The News Minute - October 15th, 2022 [October 15th, 2022]
- New Bayonetta 3 Trailer Reveals An In-Universe Singularity, And Lots Of Witches - Gameranx - October 13th, 2022 [October 13th, 2022]
- Singularity Future Technology Announces Receipt of Nasdaq Notice of Delisting and Intention to Request Hearing - Yahoo Finance - October 13th, 2022 [October 13th, 2022]
- Six Recent Discoveries That Have Changed How We Think About Human Origins - Singularity Hub - October 13th, 2022 [October 13th, 2022]
- This AI Uses a Scan of Your Retina to Predict Your Risk of Heart Disease - Singularity Hub - October 13th, 2022 [October 13th, 2022]
- The Moon May Have Formed Just Hours After Earth Collided With a Protoplanet - Singularity Hub - October 13th, 2022 [October 13th, 2022]
- UK HealthCare hosting 2 nationally esteemed guests for 60th anniversary symposium - UKNow - October 13th, 2022 [October 13th, 2022]
- Why Transcend Fund believes the opportunity for game investments is only getting bigger - VentureBeat - October 13th, 2022 [October 13th, 2022]
- Austin Powers References in This Fool, Ramy, Bros - Vulture - October 13th, 2022 [October 13th, 2022]
- Bayonetta 3 Everything You Need to Know About this Bewitching Beat em Up - Wccftech - October 8th, 2022 [October 8th, 2022]
- Longtermism: The Future Is VastWhat Does This Mean for Our Own Life? - Singularity Hub - October 8th, 2022 [October 8th, 2022]
- Ohio creates elections integrity office while voter fraud is already 'exceedingly rare' - ideastream - October 8th, 2022 [October 8th, 2022]
- Elon Musk Warns of World War III - TheStreet - October 8th, 2022 [October 8th, 2022]
- Durga reminds us of our collective obligations - Daily Pioneer - October 8th, 2022 [October 8th, 2022]
- Glitch in the algorithm - The Bucknellian - October 8th, 2022 [October 8th, 2022]
- As the Robot Fry Cook Takes Over the Kitchen - Walter Bradley Center for Natural and Artificial Intelligence - October 8th, 2022 [October 8th, 2022]
- The Singularity Image Format (SIF) Selected as a Finalist in the HPCwire Readers' Choice Awards - PR Web - October 6th, 2022 [October 6th, 2022]
- The Singularity Image Format (SIF) Selected as a Finalist in the HPCwire Readers' Choice Awards - Benzinga - October 6th, 2022 [October 6th, 2022]
- The Singularity of the Dual Mandate - Federal Reserve Bank of San Francisco - October 6th, 2022 [October 6th, 2022]
- What Is the Quirk Singularity Doomsday Theory in My Hero Academia? Explained - Twinfinite - October 6th, 2022 [October 6th, 2022]
- Introduction to week 4 of Tekedia Mini-MBA: Exponential Technologies and Singularity - Tekedia - October 6th, 2022 [October 6th, 2022]
- A $500 Million International Project Will Create the Most Detailed Map of the Brain Ever - Singularity Hub - October 6th, 2022 [October 6th, 2022]
- There Are Cheaper, More Sustainable Ways Than Desalination to Meet Our Water Needs - Singularity Hub - October 6th, 2022 [October 6th, 2022]
- #3DStartup: Unlimited Tomorrow and its 3D Printed Bionic Prosthetic Arm - 3Dnatives - October 6th, 2022 [October 6th, 2022]
- First As Parody, Then As Free Speech: The Onion Goes To The Supreme Court. It's About As Awesome As You'd Suspect. - Above the Law - October 6th, 2022 [October 6th, 2022]
- 10 Hot Cyber Threat Intelligence Tools And Services In 2022 - CRN - October 6th, 2022 [October 6th, 2022]
- Nintendo comes out strong with its offering of upcoming titles - The UML Connector - October 6th, 2022 [October 6th, 2022]
- The metaverses evolutionary roots could aid its success | Mint - Mint - October 6th, 2022 [October 6th, 2022]
- The Tech That Will Push VR to the Limits of the Human Eye - Singularity Hub - September 27th, 2022 [September 27th, 2022]
- Super-Earths Are Bigger and More Habitable Than Earth, and Astronomers Are Discovering More of the Billions They Think Are Out There - Singularity Hub - September 27th, 2022 [September 27th, 2022]
- Scientists Have Long Dreamed of a Memory Prosthesis. The First Human Trials Look Promising - Singularity Hub - September 27th, 2022 [September 27th, 2022]
- NASA's DART Spacecraft Will Smack an Asteroid at 14,000 MPH Todayand You Can Watch - Singularity Hub - September 27th, 2022 [September 27th, 2022]
- Why You Should Read This: 'The Gold Coast' - Alta Magazine - September 27th, 2022 [September 27th, 2022]
- The Multitude of Stromae - Mail and Guardian - September 27th, 2022 [September 27th, 2022]
- Warhammer 40,000: Space Marine is Getting a Location-based VR Experience Next Year - Road to VR - September 27th, 2022 [September 27th, 2022]
- What the pandemic taught us about teaching (On the Other Hand) - Montclair Local - September 27th, 2022 [September 27th, 2022]
- Where to get the Boom Sniper in Fortnite Chapter 3 Season 4 - The Nerd Stash - September 27th, 2022 [September 27th, 2022]
- Machine learning has predicted the winners of the Worlds - CyclingTips - September 27th, 2022 [September 27th, 2022]
- Vaonis Vespera Review: Easy To Use But with Underwhelming Results - PetaPixel - September 27th, 2022 [September 27th, 2022]
- The biggest problem with gravity and quantum physics - Big Think - September 27th, 2022 [September 27th, 2022]
- V gets inked on his butt cheek? BTS star spills the details about his friendship tattoo - Zoom TV - September 27th, 2022 [September 27th, 2022]
- Robots & Humans: Are we heading towards Singularity? - INDIAai - September 20th, 2022 [September 20th, 2022]
- This Week's Awesome Tech Stories From Around the Web (Through September 17) - Singularity Hub - September 20th, 2022 [September 20th, 2022]
- A Swedish Company Wants to Transform Offshore Wind With Vertical-Axis Turbines - Singularity Hub - September 20th, 2022 [September 20th, 2022]
- Decarbonizing the Energy Sector by 2050 Could Save the World $12 Trillion - Singularity Hub - September 20th, 2022 [September 20th, 2022]
- This Sleek Solar Car Goes 600 Miles on a Charge and Is Gearing Up for Production - Singularity Hub - September 20th, 2022 [September 20th, 2022]
- Meta Built an AI That Can Guess the Words You're Hearing by Decoding Your Brainwaves - Singularity Hub - September 20th, 2022 [September 20th, 2022]
- Gory Throwback FPS 'Prodeus' Exits Early Access This Thursday, Launching for PC and Consoles [Trailer] - Bloody Disgusting - September 20th, 2022 [September 20th, 2022]
- Meet the New Vespera Telescope From Vaonis - Universe Today - September 20th, 2022 [September 20th, 2022]
- Of God and Machines - The Atlantic - September 20th, 2022 [September 20th, 2022]
- Humans Destroyed Forests for Thousands of Years. We Can Become the First Generation to Expand Them - Singularity Hub - September 20th, 2022 [September 20th, 2022]
- Intel Core i9-13900K beats the 12900K by +10% in CPU-bound games - KitGuru - September 20th, 2022 [September 20th, 2022]
- INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Singularity Future Technology Ltd. with Losses of $100000 to Contact the Firm -... - August 15th, 2022 [August 15th, 2022]
- How To Open Singularity Rock in Tower of Fantasy - Attack of the Fanboy - August 15th, 2022 [August 15th, 2022]
- Intel i9-13900K Tested in Ashes Of The Singularity, Offers Neglible Increments in Performance - Appuals - August 15th, 2022 [August 15th, 2022]